Navigation Links
Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross

WOODCLIFF LAKE, N.J., Nov. 19, 2012 /PRNewswire/ -- In conjunction with Eisai Co., Ltd., the Eisai USA Foundation, the charitable arm of Eisai Inc., announced today that it will be making a donation of $100,000 to the Hurricane Sandy New Jersey Relief Fund as well as a $50,000 donation to the American Red Cross in an effort to help provide relief to the many areas damaged by Hurricane Sandy.

(Logo: )

"The devastation caused by Hurricane Sandy has affected so many people throughout the East Coast, including many of our employees and their relatives, friends and neighbors," said Lonnel Coats, President and CEO of Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd. "We hope these donations will support efforts to help ease the burden and suffering for those whose lives have been disrupted in very challenging ways."  

Eisai USA Foundation Inc.

The Eisai USA Foundation Inc. was established in 2008 as part of Eisai's commitment to be a responsible corporate citizen and contribute to the good of the society in which it does business. The Foundation focuses its charitable giving in four areas: health-related initiatives for patients and caregivers, disaster relief efforts, innovation in medical and pharmaceutical sciences, and community activities in the areas where Eisai's U.S. employees live and work.  

Eisai Inc.

Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since that time, Eisai Inc. has rapidly grown to become a fully integrated pharmaceutical business. Eisai's key areas of commercial focus are neurology and oncology. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as manufacturing facilities in Maryland and North Carolina. The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit

Eisai Co., Ltd.

Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system.

SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
2. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
3. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
4. The Michael J. Fox Foundation Announces Fourth Quarter Participants in Partnering Program Between Awardees and Industry
5. Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer
6. National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation
7. New Jersey Health Foundation Commits $2 Million to Fund Grants
8. Henry Schein, Its Supplier Partners and The Henry Schein Cares Foundation Commit to Donate More Than $1 Million to Relief Efforts for Hurricane Sandy
9. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
10. American Board of Radiology Foundation receives grant from Varian Medical Systems for national brachytherapy registry
11. Oncology Systems Limited UK Renews Research and Collaboration Agreement with University Hospital Birmingham NHS Foundation Trust (UHB) - Radiotherapy Department
Post Your Comments:
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ... ) announced today that the first patient has been ... as a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... Canada.  --> the United States ... the Phase 1/2 clinical trial, ESSA intends to demonstrate ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
(Date:11/24/2015)... India , November 24, 2015 ... . --> adds Latest Guidebook ... report of 217 pages published in November 2015 ... its online business intelligence library at ... one of the fastest growing global economies with ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... , ... “While riding the bus, I saw a passenger in a wheelchair ... to be a convenient and comfortable way to protect them from bad weather, so ... safely travel during cold or inclement weather. In doing so, it ensures that the ...
(Date:11/25/2015)... ... 2015 , ... Privately owned Contract Development and Manufacturing Organization ... current state of the art research, development and manufacturing facility outside of Fort ... capacity as well as to support its clients’ growing research and development and ...
(Date:11/25/2015)... ... , ... Students and parents have something to be thankful for this Thanksgiving ... awards. California Casualty is proud to support the contest designed to utilize ... driving, the number one killer of young drivers. , Almost 1,000 entries of ...
(Date:11/24/2015)... ... , ... New patients who wish to seek treatment for missing teeth can ... her Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 ... Missing teeth can lead to a variety of complications if they are not replaced ...
(Date:11/24/2015)... , ... November 25, 2015 , ... ... and development solutions for drugs, biologics, consumer health and global clinical supply services, ... at the upcoming Clinical Trial Supply East Asia Conference, to be held at ...
Breaking Medicine News(10 mins):